logo
Welcome Guest! To enable all features please Login or Register.

Notification

Icon
Error

Login


Options
View
Go to last post Go to first unread
goon2019  
#1 Posted : Friday, September 06, 2019 7:31:18 PM(UTC)
goon2019

Rank: Advanced Member

Groups: Registered
Joined: 5/8/2019(UTC)
Posts: 1,470
China
Location: beijing

Exemestane (Aromasin) CAS.107868-30-4



Buy Exemestane powder, sold under the brand name Aromasin among others, is a medication used to treat breast cancer. It is a member of the class of antiestrogens known as aromatase inhibitors. Some breast cancers require estrogen to grow. Those cancers have estrogen receptors (ERs), and are called ER-positive. They may also be calledestrogen-responsive,hormonally-responsive,or hormone-receptor-positive.Aromatase is an enzyme that synthesizes estrogen. Aromatase inhibitors block the synthesis of estrogen. This lowers the estrogen level, and slows the growth of cancers.

2.Specifications:

Other name: Aromasin
Product Category: Pharmaceutical raw materials and intermediates
Product content: ≥ 99%
CAS Number: 107868-30-4
Molecular formula: C20H24O2
Molecular Weight:296.40
Packing specifications: 25kg / barrel
Molecular weight: 296.4
Appearance: White or Almost White Crystalline Powder
Assay(by HPLC): 98.0-101.2%min

Effect: This product is an adrenal cortical hormone drugs. A variety of pharmacological effects of anti-inflammatory, anti allergic and immune suppression etc..

Usage:Developed to help fight breast cancer, Aromasin is one of the most powerful estrogen suppressing compounds available for body builders taking anabolic steroids. Additionally, it also raises testosterone in the body, which is a bonus for bodybuilders during post-cycle-therapy.

Delivery:EMS,DHL,FedEx ,TNT
Delivery time:within 8 hours after payment confirmed
Payment:T/T, Western Union,Money Gram and Bitcoin
3. Applications:

Exemestane is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to it for completion of a total of five consecutive years of adjuvant hormonal therapy. US FDA approval was in October 2005.

Exemestane is also indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.
Users browsing this topic
Forum Jump  
You cannot post new topics in this forum.
You cannot reply to topics in this forum.
You cannot delete your posts in this forum.
You cannot edit your posts in this forum.
You cannot create polls in this forum.
You cannot vote in polls in this forum.